Area of research
Cardiology and Cardiovascular Medicine · Biomedical Engineering
Research interest
Research interests include Medicine, Platelet, Cardiogenic shock, Platelet activation, Shock (circulatory), and Rivaroxaban.
Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Mortality in Patients With Out-of-Hospital Cardiac Arrest Undergoing a Standardized Protocol Including Therapeutic Hypothermia and Routine Coronary Angiography
Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure
Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Modulation of platelet and monocyte function by the chemokine fractalkine (<scp>CX</scp><sub>3</sub><scp>CL</scp>1) in cardiovascular disease
The direct factor Xa inhibitor Rivaroxaban reduces platelet activation in congestive heart failure